The U.S. Is Running Out Of A Critical Childhood Cancer Drug And There Is No Suitable Replacement.
Supplies of vincristine, a crucial drug in the treatment of several childhood cancers, are running critically low after one of the two manufacturers of the drug ceased production in July.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news